Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Role of ND10 nuclear bodies in the chromatin repression of HSV-1.

Gu H, Zheng Y.

Virol J. 2016 Apr 5;13:62. doi: 10.1186/s12985-016-0516-4. Review.

2.

The function, regulation and therapeutic implications of the tumor suppressor protein, PML.

Guan D, Kao HY.

Cell Biosci. 2015 Nov 4;5:60. doi: 10.1186/s13578-015-0051-9. eCollection 2015. Review.

3.

Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.

Kim YE, Ahn JH.

PLoS Pathog. 2015 Mar 26;11(3):e1004785. doi: 10.1371/journal.ppat.1004785. eCollection 2015 Mar.

4.

Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia.

Salmon JM, Bots M, Vidacs E, Stanley KL, Atadja P, Zuber J, Johnstone RW.

Clin Epigenetics. 2015 Jan 22;7:2. doi: 10.1186/s13148-014-0034-4. eCollection 2015.

5.

Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors.

Qi YF, Huang YX, Dong Y, Zheng LH, Bao YL, Sun LG, Wu Y, Yu CL, Jiang HY, Li YX.

Comput Math Methods Med. 2014;2014:867289. doi: 10.1155/2014/867289. Epub 2014 Oct 13.

6.

Histone deacetylases in herpesvirus replication and virus-stimulated host defense.

Guise AJ, Budayeva HG, Diner BA, Cristea IM.

Viruses. 2013 Jun 27;5(7):1607-32. doi: 10.3390/v5071607. Review.

7.

HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses.

Bolden JE, Shi W, Jankowski K, Kan CY, Cluse L, Martin BP, MacKenzie KL, Smyth GK, Johnstone RW.

Cell Death Dis. 2013 Feb 28;4:e519. doi: 10.1038/cddis.2013.9.

8.

Regulation of the tumor suppressor PML by sequential post-translational modifications.

Schmitz ML, Grishina I.

Front Oncol. 2012 Dec 31;2:204. doi: 10.3389/fonc.2012.00204. eCollection 2012.

9.

Real-time transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection.

Marcinowski L, Lidschreiber M, Windhager L, Rieder M, Bosse JB, Rädle B, Bonfert T, Györy I, de Graaf M, Prazeres da Costa O, Rosenstiel P, Friedel CC, Zimmer R, Ruzsics Z, Dölken L.

PLoS Pathog. 2012 Sep;8(9):e1002908. doi: 10.1371/journal.ppat.1002908. Epub 2012 Sep 6.

10.

PML regulates PER2 nuclear localization and circadian function.

Miki T, Xu Z, Chen-Goodspeed M, Liu M, Van Oort-Jansen A, Rea MA, Zhao Z, Lee CC, Chang KS.

EMBO J. 2012 Mar 21;31(6):1427-39. doi: 10.1038/emboj.2012.1. Epub 2012 Jan 24.

11.

MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.

Peche LY, Scolz M, Ladelfa MF, Monte M, Schneider C.

Cell Death Differ. 2012 Jun;19(6):926-36. doi: 10.1038/cdd.2011.173. Epub 2011 Nov 25.

12.

Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.

Kim HJ, Song DE, Lim SY, Lee SH, Kang JL, Lee SJ, Benveniste EN, Choi YH.

PLoS One. 2011;6(10):e26264. doi: 10.1371/journal.pone.0026264. Epub 2011 Oct 12.

13.

Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies.

Tavalai N, Stamminger T.

Viruses. 2009 Dec;1(3):1240-64. doi: 10.3390/v1031240. Epub 2009 Dec 15.

14.

Bromodomains as therapeutic targets.

Muller S, Filippakopoulos P, Knapp S.

Expert Rev Mol Med. 2011 Sep 13;13:e29. doi: 10.1017/S1462399411001992. Review.

15.

Promyelocytic leukemia inhibits adipogenesis, and loss of promyelocytic leukemia results in fat accumulation in mice.

Kim MK, Yang S, Lee KH, Um JH, Liu M, Kang H, Park SJ, Chung JH.

Am J Physiol Endocrinol Metab. 2011 Dec;301(6):E1130-42. doi: 10.1152/ajpendo.00092.2011. Epub 2011 Aug 16.

16.

The nuclear bodies inside out: PML conquers the cytoplasm.

Carracedo A, Ito K, Pandolfi PP.

Curr Opin Cell Biol. 2011 Jun;23(3):360-6. doi: 10.1016/j.ceb.2011.03.011. Epub 2011 Apr 16. Review.

17.

The alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies.

Jung M, Finnen RL, Neron CE, Banfield BW.

J Virol. 2011 Jun;85(11):5301-11. doi: 10.1128/JVI.00022-11. Epub 2011 Mar 23.

18.

Regulation of E2Fs and senescence by PML nuclear bodies.

Vernier M, Bourdeau V, Gaumont-Leclerc MF, Moiseeva O, Bégin V, Saad F, Mes-Masson AM, Ferbeyre G.

Genes Dev. 2011 Jan 1;25(1):41-50. doi: 10.1101/gad.1975111.

19.

SIRT1 stabilizes PML promoting its sumoylation.

Campagna M, Herranz D, Garcia MA, Marcos-Villar L, González-Santamaría J, Gallego P, Gutierrez S, Collado M, Serrano M, Esteban M, Rivas C.

Cell Death Differ. 2011 Jan;18(1):72-9. doi: 10.1038/cdd.2010.77. Epub 2010 Jun 25.

20.

SIRT1 and p53, effect on cancer, senescence and beyond.

Yi J, Luo J.

Biochim Biophys Acta. 2010 Aug;1804(8):1684-9. doi: 10.1016/j.bbapap.2010.05.002. Epub 2010 May 13. Review.

Supplemental Content

Support Center